Eric Schwartz

CIK 1329100 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 18, 2018 · Latest: Jan. 18, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 60 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

60 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 3, 2024 IART S 4,070 $24.60 $100,122 59,511 Direct -6.40% Disposed -26.3% (price as of 2026-08-19)
June 1, 2023 IART P 2,640 $37.89 $100,030 48,597 Direct +5.74% Acquired -52.1% (price as of 2026-08-19)
March 2, 2021 IART S 4,212 $69.10 $291,049 23,528 Direct -15.18% Disposed -73.7% (price as of 2026-08-19)
Feb. 25, 2021 IART S 2,288 $69.52 $159,062 29,409 Direct -7.22% Disposed -73.9% (price as of 2026-08-19)
Dec. 5, 2019 IART S 4,007 $61.62 $246,911 31,041 Direct -11.43% Disposed -70.6% (price as of 2026-08-19)
June 25, 2018 GMED S 10b5-1 1,556 $54.59 $84,942 0 Direct -100.00% Disposed 61.6% (price as of 2026-08-19)
June 25, 2018 GMED S 10b5-1 8,444 $53.64 $452,936 1,556 Direct -84.44% Disposed 64.5% (price as of 2026-08-19)
March 28, 2018 GMED S 10b5-1 24,000 $50.00 $1,200,000 0 Direct -100.00% Disposed 76.5% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 11, 2024 IART Non- Qualified Stock Option (right to buy) Common Stock (17,890) $36.22 March 11, 2032 17,890 Acquired
March 10, 2023 IART Non-Qualified Stock Option (right to buy) Common Stock (12,419) — March 10, 2031 12,419 Acquired
March 11, 2022 IART Non-Qualified Stock Option (right to buy) Common Stock (27,539) — March 11, 2030 27,539 Acquired
March 12, 2021 IART Non- Qualified Stock Option (right to buy) Common Stock (7,267) $68.10 March 12, 2029 7,267 Acquired
March 13, 2020 IART Non-Qualified Stock Option (right to buy) Common Stock (14,390) $43.39 March 13, 2028 14,390 Acquired
March 13, 2019 IART Non-Qualified Stock Option (right to buy) Common Stock (8,845) $55.91 March 13, 2027 8,845 Acquired
June 25, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (10,000) $24.98 April 28, 2026 10,000 Disposed
March 28, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (24,000) $24.98 April 28, 2026 24,000 Disposed
Jan. 22, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (40,000) $43.77 Jan. 22, 2028 40,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 18, 2018 GMED Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (75,000) 75,000 Direct
Jan. 18, 2018 GMED Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (40,000) 40,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

IART

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019 $425,000 — — — $256,300 — $11,200 $2,245,053
2018 $57,212 — — — — — $180,000 $1,137,220

GMED

SVP
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2018 $291,934 — — $543,573 — — $16,286 $851,792
2017 $331,533 — — $333,074 $131,875 — $9,699 $806,181

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.